Scynexis – Recall of Brexafemme® (ibrexafungerp)
September 27, 2023 - Scynexis announced a consumer-level recall of two lots of Brexafemme (ibrexafungerp) tablets due to potential cross contamination with a non- antibacterial beta-lactam drug substance in the ibrexafungerp citrate used to manufacture the Brexafemme tablets.
Top